A realistic approach to evaluating the effect of baseline lipid profile in postcoronary artery bypass grafting

Ali Sheikhy1,2,3, Aida Fallahzadeh1,2,3, Saeed Sadeghian1

  • 1Cardiac Primary Prevention Research Center, Cardiovascular Diseases Research Institute, Tehran University of Medical Sciences, Tehran, Iran.

Clinical Cardiology
|August 18, 2023
PubMed

Insights

Lipid profiles show nonlinear associations with outcomes after coronary artery bypass grafting (CABG). Extreme levels of LDL-C and HDL-C impact mortality risk differently in men and women post-CABG.

Area of Science:

  • Cardiology
  • Biochemistry
  • Medical Statistics

Background:

  • Uncertainties persist regarding lipid profiles and outcomes following coronary artery bypass grafting (CABG).
  • Linear models inadequately explain the complex relationship between lipid levels and post-CABG events.

Purpose of the Study:

  • To investigate the nonlinear association between lipid profile indices and adverse outcomes after CABG.
  • To clarify the impact of lipid levels on mortality and major cerebro-cardiac events (MACCE) post-CABG.

Main Methods:

  • Analysis of 17,555 patients undergoing isolated CABG (2005-2016).
  • Utilized Restricted Cubic Splines (RCS) with Cox regression, adjusting for confounders.
  • Examined nonlinear relationships between lipid profiles and mortality/MACCE over a median 75.24-month follow-up.

Main Results:

  • Nonlinear relationships observed between LDL-C, HDL-C, and all-cause mortality.
  • Linear association found between remnant cholesterol and all-cause mortality.
  • In men, high LDL-C and low HDL-C increased mortality risk; in women, low HDL-C increased risk, while high HDL-C decreased it.

Conclusions:

  • Establishing universal cut-offs for lipid profiles post-CABG may be misleading.
  • Extreme values (very low or very high) of HDL-C and LDL-C have distinct effects on cardiovascular outcomes.
Abstract

Related Concept Videos

Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
23
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
9
Blood Studies for Cardiovascular System III: Serum Lipid Profile01:25

Blood Studies for Cardiovascular System III: Serum Lipid Profile

Understanding serum lipids is crucial for maintaining cardiovascular health and preventing heart disease and stroke.
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
194
Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
698
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
12
Peripheral Artery Disease V: Postoperative Nursing Management01:23

Peripheral Artery Disease V: Postoperative Nursing Management

During the postoperative period, it is crucial to focus on maintaining circulation, identifying and managing potential complications, and planning for discharge.Nursing AssessmentVital signs monitoring: Regularly monitor vital signs, including blood pressure, heart rate, respiratory rate, and temperature, to detect early signs of complications such as bleeding and infection.Circulation assessment: Monitor pulses, perform Doppler assessments, and check capillary refill, color, temperature, and...
12